1例华法林抗凝治疗致国际标准化比值异常病例分析

发布时间：2018-04-19 07:09

  本文选题：华法林抗凝 + 国际标准化比值　； 参考：《重庆医学》2014年27期

【摘要】：正肺动脉栓塞(pulmonary embolism,PE)是由于内源性或外源性栓子,堵塞肺动脉或其分支而引起肺循环障碍的临床和病理生理综合征,是心血管急症,其病死率仅次于恶性肿瘤和心肌梗死。研究表明,40%~60%PE与肢体静脉血栓形成有关,其主要原因为肢体或盆腔静脉血栓形成后脱落所致[1]。抗凝治疗是PE标准治疗的重要组成部分,根据指南使用华法林抗凝,由于诸多因素影响,使得华法林剂量存在明显个体化差
[Abstract]:Pulmonary embolism (PE) is a kind of clinical and pathophysiological syndrome, which is caused by endogenous or exogenous embolism, blockage of pulmonary artery or its branches. It is a cardiovascular emergency, and its mortality is second only to malignant tumor and myocardial infarction.The results showed that the main cause of venous thrombosis was the shedding of venous thrombosis in the extremity or pelvic vein [1].Anticoagulant therapy is an important part of PE standard therapy. Warfarin anticoagulant is used according to the guidelines. Because of many factors, warfarin dosage is obviously different.
【作者单位】： 达州市中心医院药学部;
【分类号】：R563.5
，

本文编号：1772085